John Roll, Ph.D.
Professor and Vice Dean for Research
Associate Vice President for Health Sciences Research, WSU
- Behavioral Health Collaborative for Rural American Indian Communities
- Clinical Trials Network: Pacific Northwest Node
- Program of Excellence in Rural Mental Health and Substance Abuse Treatment
- Washington State University Center for the Study of Addiction: Methamphetamine, Prescription, and Other Drugs of Abuse
John Roll earned a Bachelor of Arts degree in psychology from the University of Montana, a Master of Arts degree in psychology from Saint Bonaventure University, and a Ph.D. in experimental psychology from Washington State University. He completed a Postdoctoral Fellowship in Human Behavioral Pharmacology at the University of Vermont and a Postdoctoral Fellowship in Substance Abuse Research at the University of Michigan Ann Arbor. He has served as a faculty member in the Department of Psychiatry at Wayne State University, Director of Behavioral Pharmacology in UCLA’s Integrated Substance Abuse Programs, Director of the Washington Institute for Mental Health Research and Training, as the Associate Dean for Research in the Washington State University (WSU) College of Nursing, and as an Associate Vice Provost for Health Sciences at WSU. He is currently a Professor and the Senior Vice Chancellor at the WSU Health Sciences campus. He is the Founding Director of the WSU Program of Excellence in the Addictions and the Co-Director of the WSU Translational Addiction Research Center. Dr. Roll holds faculty appointments in the WSU Departments of Nursing, Psychology, Neuroscience, Prevention Science and Health Policy Administration. He also holds an appointment in the University of Washington School of Medicine- Department of Psychiatry and Behavioral Neuroscience. He was appointed by WA State Governor Gregoire as an Executive Commissioner on the Eastern State Hospital Advisory Board and as a Vice Chair of the Governor’s Council on Substance Abuse. Dr. Roll serves on multiple review committees for various agencies including NIH, CDC, SAMHSA, DVA, and the Parkinson’s and Movement Disorder Foundation. Dr. Roll’s work has focused on human behavioral pharmacology, the development and refinement of behavioral interventions for addiction and other psychiatric disorders, as well as technology transfer issues. His research has recently been funded by NIH, DOJ, BJA, CDC, SAMHSA, and WA State Life Science’s Discovery Fund. Dr. Roll is a Fellow of the following organizations: American Psychological Association, Association for Behavior Analysis International, Association for Psychological Science and the American Association for the Advancement of Science.
- Hendryx M, Trusevich Y, Coyle F, Short R, Roll J. (2010). The distribution and frequency of seclusion and/or restraint among psychiatric inpatients. Journal of Behavioral Health Services Research.
- Roll, J., Rawson, R., Ling, W. & Shoptaw, S. (Eds.) (2009). Methamphetamine Addiction: From Basic Science to Treatment. Guilford Publishing.
- Roll, J.M., Reilly, M.P., Chudzynski, J., Mercado, P. (2009). Modulating the Reinforcing effects of alcohol in humans. Psychological Record.
- Roll, J. M., Madden G. J., Rawson, R., & Petry, N. M. (2009). Facilitating the Adoption of Contingency Management for the Treatment of Substance Use Disorders. Behavior Analysis in Practice.
- Roll, J. M., Howard, J. (2008). Economic gain versus economic loss: Role of reinforcer valence in initiating abstinence. Journal of Applied Behavior Analysis.
- Petry, N. M., Roll, J. M., Rounsaville, B., Ball, S., Stitzer, M., Peirce, J. M., Blaine, J., Kirby, K., McCarty, D., Carroll, K. (2008). Serious adverse events in randomized psychosocial treatment studies: Safety or Arbitrary Edicts? Journal of Consulting and Clinical Psychology.
- Roll, JM (2007) Contingency-Management: An Evidence-Based Component of Methamphetamine Use Disorder Treatments. Addiction.
- Heinzerling, K., Shoptaw, S., Peck, J., Yang, X., Liu, J., Roll, J., & Ling, W. (2006). Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug and Alcohol Dependence.
- Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, John (2006). Contingency management for treatment of substance use disorders: A meta-analysis. Addiction.